Ohr Pharmaceutical presents data from OHR-102 Phase II study in wet-AMD
7 May 2015 | By Victoria White
Ohr Pharmaceutical presented the results from the Phase II IMPACT study evaluating OHR-102 combination therapy for the treatment of the wet-AMD at ARVO...